by Clinical Neuropsychologist Online | Saturday, October 31, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | October 31, 2026 Neuro-General Previous Page
by Clinical Neuropsychologist Online | Friday, October 30, 2026 | Dementia
Abstract INTRODUCTION Tau positron emission tomography (PET) tracers differ in kinetics, binding properties, and quantification pipelines, complicating cross-study comparisons. The CenTauR approach provides a unified framework for harmonizing tau PET quantification...
by Clinical Neuropsychologist Online | Friday, October 30, 2026 | Dementia
Abstract INTRODUCTION Limbic-predominant age-related TDP-43 encephalopathy (LATE) exhibits clinical features resembling Alzheimer’s disease (AD) and frequently occurs as a co-pathology, yet there are fewer biomarkers for LATE relative to AD. METHODS We...
by Clinical Neuropsychologist Online | Friday, October 30, 2026 | Dementia
Abstract Disease-targeted therapies (DTTs) for Alzheimer’s disease (AD) represent a major advance, yet challenges remain on how best to interpret and communicate their benefits. As clinical development increasingly targets the earliest stages of AD (before...
by Clinical Neuropsychologist Online | Friday, October 30, 2026 | Dementia
Abstract BACKGROUND Mild behavioral impairment (MBI) is an important neurobehavioral marker of dementia. This study examined associations between retinal vascular measures, MBI, and its potential neurobiological correlates. METHODS Dementia-free older adults from a...
